Report Detail
Global Pediatric Drugs and Vaccines Market Insights, Forecast to 2025
- RnM3541601 |
- 19 June, 2019 |
- Global |
- 124 Pages |
- QYResearch |
- Pharma & Healthcare
Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.
The global Pediatric Drugs and Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pediatric Drugs and Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Pediatric Drugs and Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pediatric Drugs and Vaccines in these regions.
This research report categorizes the global Pediatric Drugs and Vaccines market by top players/brands, region, type and end user. This report also studies the global Pediatric Drugs and Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Shire Pharmaceuticals Group Plc. (UK)
Market size by Product
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Market size by End User
Newborn
Infant
Child
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Pediatric Drugs and Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pediatric Drugs and Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pediatric Drugs and Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pediatric Drugs and Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Pediatric Drugs and Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pediatric Drugs and Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Pediatric Drugs and Vaccines Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Product
- 1.4.2 Diphtheria
- 1.4.3 Influenza
- 1.4.4 Hepatitis
- 1.4.5 Pneumococcal Diseases
- 1.4.6 Meningococcal Diseases
- 1.4.7 Mumps
- 1.4.8 Others
- 1.5 Market by End User
- 1.5.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by End User
- 1.5.2 Newborn
- 1.5.3 Infant
- 1.5.4 Child
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Pediatric Drugs and Vaccines Market Size
- 2.1.1 Global Pediatric Drugs and Vaccines Revenue 2014-2025
- 2.1.2 Global Pediatric Drugs and Vaccines Sales 2014-2025
- 2.2 Pediatric Drugs and Vaccines Growth Rate by Regions
- 2.2.1 Global Pediatric Drugs and Vaccines Sales by Regions
- 2.2.2 Global Pediatric Drugs and Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Pediatric Drugs and Vaccines Sales by Manufacturers
- 3.1.1 Pediatric Drugs and Vaccines Sales by Manufacturers
- 3.1.2 Pediatric Drugs and Vaccines Sales Market Share by Manufacturers
- 3.1.3 Global Pediatric Drugs and Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.2 Pediatric Drugs and Vaccines Revenue by Manufacturers
- 3.2.1 Pediatric Drugs and Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.3 Pediatric Drugs and Vaccines Price by Manufacturers
- 3.4 Pediatric Drugs and Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 Pediatric Drugs and Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Pediatric Drugs and Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into Pediatric Drugs and Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Pediatric Drugs and Vaccines Sales by Product
- 4.2 Global Pediatric Drugs and Vaccines Revenue by Product
- 4.3 Pediatric Drugs and Vaccines Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Pediatric Drugs and Vaccines Breakdown Data by End User
6 North America
- 6.1 North America Pediatric Drugs and Vaccines by Countries
- 6.1.1 North America Pediatric Drugs and Vaccines Sales by Countries
- 6.1.2 North America Pediatric Drugs and Vaccines Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Pediatric Drugs and Vaccines by Product
- 6.3 North America Pediatric Drugs and Vaccines by End User
7 Europe
- 7.1 Europe Pediatric Drugs and Vaccines by Countries
- 7.1.1 Europe Pediatric Drugs and Vaccines Sales by Countries
- 7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Pediatric Drugs and Vaccines by Product
- 7.3 Europe Pediatric Drugs and Vaccines by End User
8 Asia Pacific
- 8.1 Asia Pacific Pediatric Drugs and Vaccines by Countries
- 8.1.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Countries
- 8.1.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Pediatric Drugs and Vaccines by Product
- 8.3 Asia Pacific Pediatric Drugs and Vaccines by End User
9 Central & South America
- 9.1 Central & South America Pediatric Drugs and Vaccines by Countries
- 9.1.1 Central & South America Pediatric Drugs and Vaccines Sales by Countries
- 9.1.2 Central & South America Pediatric Drugs and Vaccines Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Pediatric Drugs and Vaccines by Product
- 9.3 Central & South America Pediatric Drugs and Vaccines by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Pediatric Drugs and Vaccines by Countries
- 10.1.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Countries
- 10.1.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Pediatric Drugs and Vaccines by Product
- 10.3 Middle East and Africa Pediatric Drugs and Vaccines by End User
11 Company Profiles
- 11.1 Merck & Co., Inc. (USA)
- 11.1.1 Merck & Co., Inc. (USA) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered
- 11.1.5 Merck & Co., Inc. (USA) Recent Development
- 11.2 Abbott Laboratories (USA)
- 11.2.1 Abbott Laboratories (USA) Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Products Offered
- 11.2.5 Abbott Laboratories (USA) Recent Development
- 11.3 Amgen, Inc. (USA)
- 11.3.1 Amgen, Inc. (USA) Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
- 11.3.5 Amgen, Inc. (USA) Recent Development
- 11.4 Eli Lilly and Company (USA)
- 11.4.1 Eli Lilly and Company (USA) Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Products Offered
- 11.4.5 Eli Lilly and Company (USA) Recent Development
- 11.5 F. Hoffmann-La Roche Ltd (Switzerland)
- 11.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Details
- 11.5.2 Company Business Overview
- 11.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Products Offered
- 11.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
- 11.6 Genentech, Inc. (USA)
- 11.6.1 Genentech, Inc. (USA) Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
- 11.6.5 Genentech, Inc. (USA) Recent Development
- 11.7 GlaxoSmithKline plc. (UK)
- 11.7.1 GlaxoSmithKline plc. (UK) Company Details
- 11.7.2 Company Business Overview
- 11.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Products Offered
- 11.7.5 GlaxoSmithKline plc. (UK) Recent Development
- 11.8 Janssen Biologics B.V. (USA)
- 11.8.1 Janssen Biologics B.V. (USA) Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Products Offered
- 11.8.5 Janssen Biologics B.V. (USA) Recent Development
- 11.9 Actelion Pharmaceuticals
- 11.9.1 Actelion Pharmaceuticals Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Products Offered
- 11.9.5 Actelion Pharmaceuticals Recent Development
- 11.10 AstraZeneca Plc. (UK)
- 11.10.1 AstraZeneca Plc. (UK) Company Details
- 11.10.2 Company Business Overview
- 11.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Products Offered
- 11.10.5 AstraZeneca Plc. (UK) Recent Development
- 11.11 Boehringer Ingelheim GmbH (Germany)
- 11.12 Bristol-Myers Squibb Company (USA)
- 11.13 Allergan, Inc. (USA)
- 11.14 Novartis AG (Switzerland)
- 11.15 Novo Nordisk A/S (Denmark)
- 11.16 Pfizer, Inc. (USA)
- 11.17 Sanofi S.A (France)
- 11.18 Shionogi Inc. (USA)
- 11.19 Shire Pharmaceuticals Group Plc. (UK)
12 Future Forecast
- 12.1 Pediatric Drugs and Vaccines Market Forecast by Regions
- 12.1.1 Global Pediatric Drugs and Vaccines Sales Forecast by Regions 2019-2025
- 12.1.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Regions 2019-2025
- 12.2 Pediatric Drugs and Vaccines Market Forecast by Product
- 12.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Product 2019-2025
- 12.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Product 2019-2025
- 12.3 Pediatric Drugs and Vaccines Market Forecast by End User
- 12.4 North America Pediatric Drugs and Vaccines Forecast
- 12.5 Europe Pediatric Drugs and Vaccines Forecast
- 12.6 Asia Pacific Pediatric Drugs and Vaccines Forecast
- 12.7 Central & South America Pediatric Drugs and Vaccines Forecast
- 12.8 Middle East and Africa Pediatric Drugs and Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Pediatric Drugs and Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Pediatric Drugs and Vaccines . Industry analysis & Market Report on Pediatric Drugs and Vaccines is a syndicated market report, published as Global Pediatric Drugs and Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Pediatric Drugs and Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
